Business

July 22, 2014

Cancer Genetics completes $6.25M acquisition of Morrisville-based Gentris

Cancer Genetics, a publicly-traded New Jersey company, has completed its $6.25 million acquisition of Morrisville-based pharmacogenomics business Gentris Corp.

Related content

Comments

Videos

Editor's Choice Videos